219 related articles for article (PubMed ID: 20021829)
1. [Case-control study of risk factors in cholangiocarcinoma].
Tao LY; He XD; Cai L; Liu W; Ji WJ; Zhao L; Zhang SM
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):759-63. PubMed ID: 20021829
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors of intrahepatic cholangiocarcinoma: a case-control study].
Zhou HB; Xu QR; Wang H; Zhou DX; Wang H; Wang Q; Zhou SS; Tu QQ; Sun ZQ; Ai L; Wu MC; Hu HP
Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):935-9. PubMed ID: 20038337
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study.
Lee TY; Lee SS; Jung SW; Jeon SH; Yun SC; Oh HC; Kwon S; Lee SK; Seo DW; Kim MH; Suh DJ
Am J Gastroenterol; 2008 Jul; 103(7):1716-20. PubMed ID: 18557716
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus and intrahepatic cholangiocarcinoma.
Gatselis NK; Tepetes K; Loukopoulos A; Vasiou K; Zafiriou A; Gioti C; Dalekos GN
Cancer Invest; 2007 Feb; 25(1):55-8. PubMed ID: 17364558
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
Qu Z; Cui N; Qin M; Wu X
Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus.
Peng NF; Li LQ; Qin X; Guo Y; Peng T; Xiao KY; Chen XG; Yang YF; Su ZX; Chen B; Su M; Qi LN
Ann Surg Oncol; 2011 May; 18(5):1258-66. PubMed ID: 21207172
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma: new insights in pathology.
Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of cholangiocarcinoma.
Shaib Y; El-Serag HB
Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
[TBL] [Abstract][Full Text] [Related]
12. Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.
Torbenson M; Yeh MM; Abraham SC
Am J Surg Pathol; 2007 Sep; 31(9):1410-3. PubMed ID: 17721197
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
[TBL] [Abstract][Full Text] [Related]
14. [The retrospective analysis of HBV and HCV infection in cholangiocarcinoma].
Zou SQ; Liu XF; Guo RX; Li CL; Zhou XS; Zhu XG; Huang ZQ
Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):417-9. PubMed ID: 12895347
[TBL] [Abstract][Full Text] [Related]
15. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological comparison between intrahepatic cholangiocarcinoma arising in livers positive and negative for hepatitis B or C virus.
Wakabayashi H; Hashimoto N; Okano K; Inoue T; Kakinoki K; Izuishi K; Suzuki Y
Liver Int; 2008 May; 28(5):717-8. PubMed ID: 18433399
[No Abstract] [Full Text] [Related]
17. Pathogenesis of cholangiocarcinoma in the porta hepatis and infection of hepatitis virus.
Liu XF; Zou SQ; Qiu FZ
Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):285-9. PubMed ID: 14599986
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenesis of hilar cholangiocarcinoma and infection of hepatitis virus].
Liu X; Zou S; Qiu F
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):420-2. PubMed ID: 12139797
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience.
Portolani N; Baiocchi GL; Coniglio A; Piardi T; Grazioli L; Benetti A; Ferrari Bravo A; Giulini SM
Ann Surg Oncol; 2008 Jul; 15(7):1880-90. PubMed ID: 18443881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
